Latest News

Cognex (NasdaqGS:CGNX) reported Q4 2025 results that marked a return to profitable growth. Management highlighted an operational turnaround helped by portfolio optimization and cost actions. The quarter included launches of new AI-powered machine vision products and strong new customer intake. Cognex, trading at $58.79, is back in focus after Q4 2025 results showed a shift to profitable growth supported by operational changes. The stock has been strong recently, up 34.5% over the past week,...

Why Suncor’s recent board move and capital returns matter Suncor Energy (TSX:SU) has been in focus after appointing Jennifer Kneale to its board, while also confirming a CA$0.60 quarterly dividend and completing a multi billion dollar share buyback program. See our latest analysis for Suncor Energy. Suncor’s recent board appointment, dividend affirmation and completion of a multi billion dollar buyback come as the share price trades at CA$76.25, with a 30 day share price return of 10.33% and...

EVZ Limited ( ASX:EVZ ) shares have continued their recent momentum with a 30% gain in the last month alone. The last...

Constellation Brands (NYSE:STZ) has appointed Nicholas Fink as its new CEO, succeeding Bill Newlands. Newlands will remain with the company in an advisory capacity during the leadership transition. Fink previously held senior roles at Fortune Brands Innovations and Suntory Global Spirits. Constellation Brands, the owner of a broad portfolio of beer, wine and spirits labels, operates in a highly competitive consumer beverages market where brand strength and distribution relationships are...

American Express stock snapshot American Express (AXP) has drawn investor attention after a period of mixed recent returns, with the share price around $337.50 and one year total return close to 9.7%. See our latest analysis for American Express. Recent trading has been softer, with a 1-day share price return of a 1.6% decline, a 7-day share price return of a 6.2% decline, and a 30-day share price return of a 7.5% decline. The 1-year total shareholder return of 9.7% and 5-year total...

If you are wondering whether Radian Group at around US$32.82 is offering good value or not, this article is going to focus squarely on what the current price might mean for long term investors. The stock is roughly flat over the last 7 days at 0.2%, slightly lower over the past month with a 0.9% decline, and shows longer term returns of 3.2% over 1 year, 60.7% over 3 years, and 88.6% over 5 years. Recent coverage around Radian Group has mainly centered on its position in the US mortgage...

Snowline Gold (TSX:SGD) has put fresh drilling and assay results from its Valley deposit on the Rogue Project in front of investors, highlighting consistent high grade, near surface gold mineralization. See our latest analysis for Snowline Gold. Those fresh drill and assay results land after a period of strong momentum, with a 90 day share price return of 43.94% and a very large 3 year total shareholder return. However, the 7 day share price return of 5.35% and year to date share price return...

If you are wondering whether SCR-Sibelco is priced fairly today, you are not alone. The stock often attracts attention from investors trying to work out if they might be overpaying or missing an opportunity. Over the short term, the share price has been mixed, with a 1.3% return over the last 7 days, a 0.8% decline over 30 days, and returns of 12.7% decline year to date and 5.7% decline over the past year, extending to a 10.9% decline over five years. Recent news coverage has mainly focused...

W. P. Carey (WPC) is back in focus after a packed fourth quarter, with FFO and revenue above expectations, fresh 2026 guidance, a dividend increase, heavy portfolio activity, and a €1 billion senior unsecured notes offering. See our latest analysis for W. P. Carey. The recent earnings beat, higher 2026 AFFO guidance and the €1b senior unsecured notes offering appear to sit behind a clear shift in sentiment, with a 10.95% 3 month share price return and a 33.76% 1 year total shareholder return...

H World Group (HTHT) has launched Hanting Inn, a new economy hotel brand aimed at lower tier cities and price sensitive markets, using a low investment, asset light model tailored for faster expansion. See our latest analysis for H World Group. H World Group’s new Hanting Inn launch comes as the share price sits at US$52.53, with a 30 day share price return of 7.12% and a 90 day share price return of 16.17%. The 1 year total shareholder return of 51.79% suggests momentum has been building...

Baxter International (NYSE:BAX) is rolling out a new decentralized operating model after a challenging fourth quarter and full year. The company is separating its Kidney Care business and reshaping its board as part of a broad restructuring effort. Management is also working to streamline operations following margin pressure, operational issues, and a sizeable goodwill impairment. Baxter International enters this restructuring phase with its shares at $19.79 and a difficult recent track...

Why Heiwa’s latest earnings and board decision matter for investors Heiwa (TSE:6412) has just reported nine month earnings to December 31, 2025, alongside a board decision on an additional shareholder benefit grant. This puts both profitability and capital return policy in focus for investors. The company reported sales of ¥206,554 million for the period, compared with ¥118,782 million a year earlier, while net income was ¥17,056 million versus ¥20,583 million. Basic earnings per share from...

CACI International Executive Vice President and General Counsel, William Koegel, sold 2,000 shares of NYSE:CACI. This was his latest transaction in a pattern of insider selling over the past year, with no insider purchases reported in that period. The activity comes with CACI International shares recently closing at $573.3. For investors watching NYSE:CACI, this cluster of insider sales is arriving after a strong longer term share move, with the stock up 69.4% over the past year and 144.7%...

If you are wondering whether Lloyds Banking Group is still good value after its recent run, this article walks through the key numbers so you can judge the current share price for yourself. The stock has seen a mixed pattern recently, with a 3.7% decline over the last 7 days and a 0.7% decline over the last 30 days, but sits on a 2.2% gain year to date and a 69.2% return over the last year. That longer term performance stands out even more over multi year periods, with returns of 130.0% over...

In early February 2026, Merck received FDA approval for KEYTRUDA and KEYTRUDA QLEX plus paclitaxel, with or without bevacizumab, for adults with PD-L1 positive, platinum-resistant epithelial ovarian, fallopian tube or primary peritoneal carcinoma after one or two prior systemic treatments. This marks the first approval of a PD-1 inhibitor regimen for this hard-to-treat setting, broadening KEYTRUDA’s reach in women’s cancers and reinforcing Merck’s oncology franchise. Next, we’ll examine how...

Boralex (TSX:BLX) is in the spotlight after announcing that its consented Sallachy Wind Farm in Scotland secured a Contract for Difference in the United Kingdom Government's Allocation Round 7. See our latest analysis for Boralex. The CfD win comes on the back of a quarterly dividend declaration and has coincided with a 1-year total shareholder return of 9.21%, even as the 3-year and 5-year total shareholder returns of 21.19% and 29.91% declines show longer term momentum has been weaker. If...

What recent returns say about NewMarket With no single headline event setting the tone, NewMarket (NEU) has been moving under the radar. The stock has shown a 0.7% decline over the past day and weaker performance over the past week. See our latest analysis for NewMarket. Beyond the latest 0.7% daily share price decline, NewMarket’s recent 7 day and 90 day share price returns of 17.0% and 21.1% point to fading short term momentum. At the same time, 1 year and 3 year total shareholder returns...

If you are wondering whether South32 is attractively priced or already fully valued, this article will walk through what the current numbers may be telling you about the stock. South32's share price last closed at A$4.41, with returns of 6.0% over the past month and 24.2% year to date, while the 1 year return sits at 23.2% after a 3.1% decline in the last week. Recent moves in the share price are set against ongoing market interest in resource producers like South32 and how they are...

Earnings event and why it matters for Dexerials (TSE:4980) Dexerials (TSE:4980) has just posted nine month earnings to December 31, 2025, with sales of ¥87,296 million and net income of ¥21,267 million, alongside lower basic and diluted EPS versus a year earlier. See our latest analysis for Dexerials. The latest 1 day share price return of 2.95% to ¥2,302.5 comes after weak recent momentum, with a 7 day share price return of a 25.61% decline and a 90 day share price return of a 24.90%...

Innovent Biologics (SEHK:1801) has caught investor attention after dosing the first participant in its pivotal Phase 3 HeriCare-Breast01 trial for IBI354, a HER2-directed antibody drug conjugate in breast cancer. See our latest analysis for Innovent Biologics. That Phase 3 milestone comes on the back of an eventful few weeks, including a new collaboration with Eli Lilly and strong 2025 product revenue figures. The share price has a year to date return of 13.07% alongside a 1 year total...

Why Maplebear’s recent performance has investors taking a closer look Maplebear (CART), better known as Instacart, has drawn investor attention after a mixed run, with the share price up over the past week but showing weaker returns over the past month and past 3 months. See our latest analysis for Maplebear. At around $36.30, the latest move, including a 1 day share price return of 9.21% and a year to date share price return decline of 17.33%, points to short term momentum but weaker longer...

Two Harbors Investment Corp. recently reported fourth-quarter 2025 results, with net income falling to US$11.72 million and a basic loss per share from continuing operations of US$0.02, compared with basic earnings per share of US$2.54 a year earlier. For the full year 2025, the company moved from net income of US$298.17 million to a net loss of US$454.30 million, underscoring a sharp swing in profitability that reframes how investors may view its risk and return profile. Against this...

Vital Farms recently reported quarterly results showing a 37.2% year-over-year revenue increase and an earnings per share beat, while also preparing to release its fourth-quarter and full-year 2025 results on February 26, 2026. At the same time, the company’s valuation is graded favorably versus peers even as consensus earnings estimates have softened slightly, creating a nuanced picture for investors. Next, we’ll examine how Vital Farms’ combination of strong recent revenue growth and a...

Asahi Intecc (TSE:7747) has raised its full year earnings guidance and outlined higher ordinary and commemorative dividends for the fiscal year ending June 30, 2026, following a recent board meeting. See our latest analysis for Asahi Intecc. The guidance upgrade and higher dividend plans arrived alongside a sharp 1 day share price return of 11.15% and a 7 day share price return of 13.27%, while the 1 year total shareholder return sits at 9.16%. This suggests momentum has recently picked up...